APO Research
Talk to an analyst

APO RESEARCH · REPORT

Life Sciences Insurance

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Life Sciences Insurance Market Outlook and Growth Opportunities 2026

2 May 2026190 pages

Choose your research edition.

Industry ResearchLife Sciences Insurance Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Life Sciences Insurance Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Life Sciences Insurance Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Life Sciences Insurance Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Life Sciences Insurance Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Life Sciences Insurance market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Life Sciences Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Life Sciences Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Life Sciences Insurance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Life Sciences Insurance market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Life Sciences Insurance market include Zurich, Markel, AXA XL, Chubb, Travelers Insurance, HDI Global, Sompo International, USI and WTW, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Life Sciences Insurance market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Life Sciences Insurance and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Life Sciences Insurance revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Life Sciences Insurance market.

Life Sciences Insurance Segment by Company

Zurich

Markel

AXA XL

Chubb

Travelers Insurance

HDI Global

Sompo International

USI

WTW

Kinsale

CFC Underwriting

Liberty Mutual Business Insurance

Newline Australia

W. R. Berkley

Life Sciences Insurance Segment by Type

General Liability Insurance

Commercial Property Insurance

Business Income Insurance

Life Sciences Insurance Segment by Application

Biotechnology Companies

Medical Device Companies

Nutraceutical Companies

Life Science Service Organizations

Others

Life Sciences Insurance Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Life Sciences Insurance status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Life Sciences Insurance key companies, revenue, market share, and recent developments.

3. To split the Life Sciences Insurance breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Life Sciences Insurance market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Life Sciences Insurance significant trends, drivers, influence factors in global and regions.

6. To analyze Life Sciences Insurance competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Life Sciences Insurance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Life Sciences Insurance and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Life Sciences Insurance.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Life Sciences Insurance industry.

Chapter 3: Detailed analysis of Life Sciences Insurance company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Life Sciences Insurance in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Life Sciences Insurance in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Life Sciences Insurance Industry Trends Table 2. Life Sciences Insurance Industry Drivers Table 3. Life Sciences Insurance Industry Opportunities and Challenges Table 4. Life Sciences Insurance Industry Restraints Table 5. Global Life Sciences Insurance Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Life Sciences Insurance Revenue Share by Company (2021-2026) Table 7. Global Life Sciences Insurance Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Life Sciences Insurance Key Company Manufacturing Base & Headquarters Table 9. Global Life Sciences Insurance Company, Product Type & Application Table 10. Global Life Sciences Insurance Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Life Sciences Insurance by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of General Liability Insurance Table 15. Significant Companies of Commercial Property Insurance Table 16. Significant Companies of Business Income Insurance Table 17. Global Life Sciences Insurance Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Life Sciences Insurance Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Life Sciences Insurance Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Life Sciences Insurance Sales Value Share by Type (2021-2026) Table 21. Global Life Sciences Insurance Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biotechnology Companies Table 23. Significant Companies of Medical Device Companies Table 24. Significant Companies of Nutraceutical Companies Table 25. Significant Companies of Life Science Service Organizations Table 26. Significant Companies of Others Table 27. Global Life Sciences Insurance Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Life Sciences Insurance Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Life Sciences Insurance Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Life Sciences Insurance Sales Value Share by Application (2021-2026) Table 31. Global Life Sciences Insurance Sales Value Share by Application (2027-2032) Table 32. Global Life Sciences Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Life Sciences Insurance Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Life Sciences Insurance Sales Value Share by Region (2021-2026) Table 35. Global Life Sciences Insurance Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Life Sciences Insurance Sales Value Share by Region (2027-2032) Table 37. Global Life Sciences Insurance Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Life Sciences Insurance Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Life Sciences Insurance Sales Value Market Share by Country (2021-2026) Table 40. Global Life Sciences Insurance Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Life Sciences Insurance Sales Value Market Share by Country (2027-2032) Table 42. Zurich Company Information Table 43. Zurich Business Overview Table 44. Zurich Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Zurich Life Sciences Insurance Product Portfolio Table 46. Zurich Recent Development Table 47. Markel Company Information Table 48. Markel Business Overview Table 49. Markel Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Markel Life Sciences Insurance Product Portfolio Table 51. Markel Recent Development Table 52. AXA XL Company Information Table 53. AXA XL Business Overview Table 54. AXA XL Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. AXA XL Life Sciences Insurance Product Portfolio Table 56. AXA XL Recent Development Table 57. Chubb Company Information Table 58. Chubb Business Overview Table 59. Chubb Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Chubb Life Sciences Insurance Product Portfolio Table 61. Chubb Recent Development Table 62. Travelers Insurance Company Information Table 63. Travelers Insurance Business Overview Table 64. Travelers Insurance Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Travelers Insurance Life Sciences Insurance Product Portfolio Table 66. Travelers Insurance Recent Development Table 67. HDI Global Company Information Table 68. HDI Global Business Overview Table 69. HDI Global Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. HDI Global Life Sciences Insurance Product Portfolio Table 71. HDI Global Recent Development Table 72. Sompo International Company Information Table 73. Sompo International Business Overview Table 74. Sompo International Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sompo International Life Sciences Insurance Product Portfolio Table 76. Sompo International Recent Development Table 77. USI Company Information Table 78. USI Business Overview Table 79. USI Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. USI Life Sciences Insurance Product Portfolio Table 81. USI Recent Development Table 82. WTW Company Information Table 83. WTW Business Overview Table 84. WTW Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. WTW Life Sciences Insurance Product Portfolio Table 86. WTW Recent Development Table 87. Kinsale Company Information Table 88. Kinsale Business Overview Table 89. Kinsale Life Sciences Insurance Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Kinsale Life Sciences Insurance Product Portfolio Table 91. Kinsale Recent Development Table 92. CFC Underwriting Company Information Table 93. CFC Underwriting Business Overview Table 94. CFC Underwriting Life Sciences Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. CFC Underwriting Life Sciences Insurance Product Portfolio Table 96. CFC Underwriting Recent Development Table 97. Liberty Mutual Business Insurance Company Information Table 98. Liberty Mutual Business Insurance Business Overview Table 99. Liberty Mutual Business Insurance Life Sciences Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Liberty Mutual Business Insurance Life Sciences Insurance Product Portfolio Table 101. Liberty Mutual Business Insurance Recent Development Table 102. Newline Australia Company Information Table 103. Newline Australia Business Overview Table 104. Newline Australia Life Sciences Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Newline Australia Life Sciences Insurance Product Portfolio Table 106. Newline Australia Recent Development Table 107. W. R. Berkley Company Information Table 108. W. R. Berkley Business Overview Table 109. W. R. Berkley Life Sciences Insurance Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. W. R. Berkley Life Sciences Insurance Product Portfolio Table 111. W. R. Berkley Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Life Sciences Insurance Product Image Figure 2. Global Life Sciences Insurance Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Life Sciences Insurance Market Size (2021-2032) & (US$ Million) Figure 4. Global Life Sciences Insurance Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. General Liability Insurance Image Figure 8. Commercial Property Insurance Image Figure 9. Business Income Insurance Image Figure 10. Global Life Sciences Insurance Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Life Sciences Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Life Sciences Insurance Sales Value Share by Type (2021-2032) Figure 13. Biotechnology Companies Image Figure 14. Medical Device Companies Image Figure 15. Nutraceutical Companies Image Figure 16. Life Science Service Organizations Image Figure 17. Others Image Figure 18. Global Life Sciences Insurance Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Life Sciences Insurance Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Life Sciences Insurance Sales Value Share by Application (2021-2032) Figure 21. Global Life Sciences Insurance Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Life Sciences Insurance Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Life Sciences Insurance Sales Value (2021-2032) & (US$ Million) Figure 24. North America Life Sciences Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Life Sciences Insurance Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Life Sciences Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Life Sciences Insurance Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Life Sciences Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Life Sciences Insurance Sales Value (2021-2032) & (US$ Million) Figure 30. South America Life Sciences Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Life Sciences Insurance Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Life Sciences Insurance Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Life Sciences Insurance Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • General Liability Insurance
  • Commercial Property Insurance
  • Business Income Insurance
Applications
  • Biotechnology Companies
  • Medical Device Companies
  • Nutraceutical Companies
  • Life Science Service Organizations
  • Others
Companies covered
  • Zurich
  • Markel
  • AXA XL
  • Chubb
  • Travelers Insurance
  • HDI Global
  • Sompo International
  • USI
  • WTW
  • Kinsale
  • CFC Underwriting
  • Liberty Mutual Business Insurance
  • Newline Australia
  • W. R. Berkley

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Life Sciences Insurance Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Life Sciences Insurance Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Life Sciences Insurance Market Dynamics
  1. 2.1 Life Sciences Insurance Industry Trends
  2. 2.2 Life Sciences Insurance Industry Drivers
  3. 2.3 Life Sciences Insurance Industry Opportunities and Challenges
  4. 2.4 Life Sciences Insurance Industry Restraints
3 Life Sciences Insurance Market by Company
  1. 3.1 Global Life Sciences Insurance Company Revenue Ranking in 2025
  2. 3.2 Global Life Sciences Insurance Revenue by Company (2021-2026)
  3. 3.3 Global Life Sciences Insurance Company Ranking (2024-2026)
  4. 3.4 Global Life Sciences Insurance Company Manufacturing Base and Headquarters
  5. 3.5 Global Life Sciences Insurance Company Product Type and Application
  6. 3.6 Global Life Sciences Insurance Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Life Sciences Insurance Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Life Sciences Insurance Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Life Sciences Insurance Market by Type
  1. 4.1 Life Sciences Insurance Type Introduction
  2. 4.1.1 General Liability Insurance
  3. 4.1.2 Commercial Property Insurance
  4. 4.1.3 Business Income Insurance
  5. 4.2 Global Life Sciences Insurance Sales Value by Type
  6. 4.2.1 Global Life Sciences Insurance Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Life Sciences Insurance Sales Value by Type (2021-2032)
  8. 4.2.3 Global Life Sciences Insurance Sales Value Share by Type (2021-2032)
5 Life Sciences Insurance Market by Application
  1. 5.1 Life Sciences Insurance Application Introduction
  2. 5.1.1 Biotechnology Companies
  3. 5.1.2 Medical Device Companies
  4. 5.1.3 Nutraceutical Companies
  5. 5.1.4 Life Science Service Organizations
  6. 5.1.5 Others
  7. 5.2 Global Life Sciences Insurance Sales Value by Application
  8. 5.2.1 Global Life Sciences Insurance Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Life Sciences Insurance Sales Value by Application (2021-2032)
  10. 5.2.3 Global Life Sciences Insurance Sales Value Share by Application (2021-2032)
6 Life Sciences Insurance Regional Value Analysis
  1. 6.1 Global Life Sciences Insurance Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Life Sciences Insurance Sales Value by Region (2021-2032)
  3. 6.2.1 Global Life Sciences Insurance Sales Value by Region: 2021-2026
  4. 6.2.2 Global Life Sciences Insurance Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Life Sciences Insurance Sales Value (2021-2032)
  7. 6.3.2 North America Life Sciences Insurance Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Life Sciences Insurance Sales Value (2021-2032)
  10. 6.4.2 Europe Life Sciences Insurance Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Life Sciences Insurance Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Life Sciences Insurance Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Life Sciences Insurance Sales Value (2021-2032)
  16. 6.6.2 South America Life Sciences Insurance Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Life Sciences Insurance Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Life Sciences Insurance Sales Value Share by Country, 2025 VS 2032
7 Life Sciences Insurance Country-level Value Analysis
  1. 7.1 Global Life Sciences Insurance Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Life Sciences Insurance Sales Value by Country (2021-2032)
  3. 7.2.1 Global Life Sciences Insurance Sales Value by Country (2021-2026)
  4. 7.2.2 Global Life Sciences Insurance Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Life Sciences Insurance Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Life Sciences Insurance Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Life Sciences Insurance Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zurich
  2. 8.1.1 Zurich Company Information
  3. 8.1.2 Zurich Business Overview
  4. 8.1.3 Zurich Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zurich Life Sciences Insurance Product Portfolio
  6. 8.1.5 Zurich Recent Developments
  7. 8.2 Markel
  8. 8.2.1 Markel Company Information
  9. 8.2.2 Markel Business Overview
  10. 8.2.3 Markel Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Markel Life Sciences Insurance Product Portfolio
  12. 8.2.5 Markel Recent Developments
  13. 8.3 AXA XL
  14. 8.3.1 AXA XL Company Information
  15. 8.3.2 AXA XL Business Overview
  16. 8.3.3 AXA XL Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AXA XL Life Sciences Insurance Product Portfolio
  18. 8.3.5 AXA XL Recent Developments
  19. 8.4 Chubb
  20. 8.4.1 Chubb Company Information
  21. 8.4.2 Chubb Business Overview
  22. 8.4.3 Chubb Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Chubb Life Sciences Insurance Product Portfolio
  24. 8.4.5 Chubb Recent Developments
  25. 8.5 Travelers Insurance
  26. 8.5.1 Travelers Insurance Company Information
  27. 8.5.2 Travelers Insurance Business Overview
  28. 8.5.3 Travelers Insurance Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Travelers Insurance Life Sciences Insurance Product Portfolio
  30. 8.5.5 Travelers Insurance Recent Developments
  31. 8.6 HDI Global
  32. 8.6.1 HDI Global Company Information
  33. 8.6.2 HDI Global Business Overview
  34. 8.6.3 HDI Global Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HDI Global Life Sciences Insurance Product Portfolio
  36. 8.6.5 HDI Global Recent Developments
  37. 8.7 Sompo International
  38. 8.7.1 Sompo International Company Information
  39. 8.7.2 Sompo International Business Overview
  40. 8.7.3 Sompo International Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sompo International Life Sciences Insurance Product Portfolio
  42. 8.7.5 Sompo International Recent Developments
  43. 8.8 USI
  44. 8.8.1 USI Company Information
  45. 8.8.2 USI Business Overview
  46. 8.8.3 USI Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  47. 8.8.4 USI Life Sciences Insurance Product Portfolio
  48. 8.8.5 USI Recent Developments
  49. 8.9 WTW
  50. 8.9.1 WTW Company Information
  51. 8.9.2 WTW Business Overview
  52. 8.9.3 WTW Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  53. 8.9.4 WTW Life Sciences Insurance Product Portfolio
  54. 8.9.5 WTW Recent Developments
  55. 8.10 Kinsale
  56. 8.10.1 Kinsale Company Information
  57. 8.10.2 Kinsale Business Overview
  58. 8.10.3 Kinsale Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kinsale Life Sciences Insurance Product Portfolio
  60. 8.10.5 Kinsale Recent Developments
  61. 8.11 CFC Underwriting
  62. 8.11.1 CFC Underwriting Company Information
  63. 8.11.2 CFC Underwriting Business Overview
  64. 8.11.3 CFC Underwriting Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CFC Underwriting Life Sciences Insurance Product Portfolio
  66. 8.11.5 CFC Underwriting Recent Developments
  67. 8.12 Liberty Mutual Business Insurance
  68. 8.12.1 Liberty Mutual Business Insurance Company Information
  69. 8.12.2 Liberty Mutual Business Insurance Business Overview
  70. 8.12.3 Liberty Mutual Business Insurance Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Liberty Mutual Business Insurance Life Sciences Insurance Product Portfolio
  72. 8.12.5 Liberty Mutual Business Insurance Recent Developments
  73. 8.13 Newline Australia
  74. 8.13.1 Newline Australia Company Information
  75. 8.13.2 Newline Australia Business Overview
  76. 8.13.3 Newline Australia Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Newline Australia Life Sciences Insurance Product Portfolio
  78. 8.13.5 Newline Australia Recent Developments
  79. 8.14 W. R. Berkley
  80. 8.14.1 W. R. Berkley Company Information
  81. 8.14.2 W. R. Berkley Business Overview
  82. 8.14.3 W. R. Berkley Life Sciences Insurance Revenue and Gross Margin (2021-2026)
  83. 8.14.4 W. R. Berkley Life Sciences Insurance Product Portfolio
  84. 8.14.5 W. R. Berkley Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst